Compositions And Methods For Site-Directed Mutagenesis - EP4262850
The patent EP4262850 was granted to Novo Nordisk on Jul 9, 2025. The application was originally filed on Dec 16, 2021. The patent is currently recorded with a legal status of "Pending".
EP4262850
- Filing Date
- Dec 16, 2021
- Status
- Pending
- Grant Date
- Jul 9, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents